Height Growth, J&J, FedEx and more

Check out the companies that make headlines before the clock:

Altimeter Growth (AGC) – The giant giant Grab in Southeast Asia is announced via a SPAC merger with Altimeter Growth, worth nearly $ 40 billion. Grab says he plans to list on the Nasdaq under the symbol “GRAB” after completing the deal. Altimeter’s shares rose nearly 9% in pre-trading.

Johnson & Johnson (JNJ) – The drugmaker’s shares fell 2.8% in the futures market after the Food and Drug Administration said it was asking countries to suspend the administration of J & J’s Covid-19 vaccine after six people in the US has developed a rare disease with blood clots. The FDA said the recommendation was “out of an abundance of caution.” Modern stocks gained more than 7% in early trading.

FedEx (FDX) – Shares of the shipping company rose in pre-trade trading on KeyBanc Capital Markets, FedEx upgraded to ‘overweight’. The Wall Street firm also set a price target of $ 350 per share on FedEx. KeyBanc said FedEx could continue to grow, even with the return to personal shopping.

JetBlue (JBLU), Spirit Airlines (SAVE) – Shares of the airlines emerged in the pre-negotiation after Susquehanna Financial Group upgraded JetBlue and Spirit Airlines to ‘positive’. “With a recovery in U.S. domestic air travel, we want to own the low-cost airline,” the firm’s analyst told clients.

Booking Holdings (BKNG) – The travel company gained in pre-negotiation after Jefferies improved Booking’s upgrade to ‘buy’ from ‘hold’ on a rebound in global travel. The former also raised its 12-month price target to $ 2,800 per share from $ 2,300 per share.

3M (MMM) – Shares of the manufacturing giant rose lower in the futures market after Deutsche Bank added a “catalyst call” to 3M. The Wall Street firm said the stock had performed better curiously over the past few weeks, despite Deutsche Bank expecting it to miss out on upcoming earnings.

NortonLifeLock (NLOK) – The security firm plunged into market trading after Bank of America started the stock with an ‘underperformance’ rating and a target of $ 19 per share. “Last year’s COVID – related increase in demand may decline in the coming quarters and the company may return to negative trends in revenue and add-on subscribers, which negatively impact revenue growth,” the firm said.

Honeywell (HON) – Shares Honeywell rose in the pre-trading market after Deutsche Bank called a catalyst ‘buy’ on the stock. The firm said investors are not enthusiastic about Honeywell, despite the recovery that is succeeding.

Bristol-Myers Squibb (BMY) – Shares of the pharmaceutical company rose in the futures market over Truist, which upgraded Bristol-Myers Squibb to buy from ‘hold’ with a target of $ 74 per share. The Wall Street firm said it likes the Bristol-Myers Squibb drug pipeline.